Perrigo announces plan to separate prescription pharmaceuticals business
Perrigo announced that its Board of Directors approved a plan to separate the Company's Prescription Pharmaceuticals business following a strategic portfolio review. The Board will consider all value-enhancing options, including a tax-efficient separation to shareholders, a sale or merger. August 09, 2018